Publications

MD Becker Partners publishes the Life Science Digest newsletter, which contains original articles on medical, financial, communications, marketing, and regulatory topics relevant to the biotechnology, pharmaceutical, and medical device industries. To view these articles, please visit the Life Science Digest newsletter site (http://lifesciencedigest.com).

6/27/2012 – “High Points and Hurdles: Immunotherapy Moves Forward” by Anita T. Shaffer of OncLive

5/7/2012 – “Insight: Training immune system to fight cancer comes of age” by Bill Berkrot of Reuters

3/2/2012 – “Biotech Stock Mailbag: Cyclacel Fallout, the Skinny on Vivus, Celldex’s Crash” by Adam Feuerstein of TheStreet.com

2/27/2012 – “Dendreon Shares Drop on Slowing Sales of Cancer Vaccine Provenge” by Brett Chase of Minyanville

1/26/2012 – “Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies” by Brett Chase of Minyanville

1/5/2012 – “Dendreon reports spike in Provenge sales; shares soar” by Bill Berkrot of Reuters

10/11/2011 – “Nobel prize-winning science should incubate deals” by David Holley of The Deal

10/7/2011 – “Zytiga creeps up on Provenge prostate-cancer drug” by Ransdell Pierson of Reuters

8/23/2011 – “What’s a Cancer Drug Worth?” by Brett Chase of Minyanville